Acutaas Chemicals Delivers Strong Q2 FY27 Results and Upgrades Annual Guidance
Acutaas Chemicals Ltd · Press Release · 27 Oct 2026, 6:29 pm
Acutaas Chemicals Delivers Strong Q2 FY27 Results and Upgrades Annual Guidance Acutaas Chemicals reported robust Q2 FY27 results, with revenue from operations surging 42.7% YoY to ₹4,369mn, led by pharmaceutical intermediates. EBITDA jumped 84.6% YoY to ₹1,760mn as EBITDA margin expanded 920 bps YoY to 40.3%, while PAT rose 71.4% YoY to ₹1,231mn with margins at 28.2%. The company inaugurated its South Korea facility ahead of schedule to produce high-purity semiconductor chemicals. Backed by strong order visibility, management revised FY27 revenue growth guidance upward from 25% to ~30% and raised EBITDA margin guidance to 38-40%.
Original exchange filing (PDF)
More announcements from Acutaas Chemicals Ltd
- Intimation of schedule of Investor Conferences/Meets is attached · 07 Nov 2026
- Annual Sustainability Report for the financial year 2025-26 is enclosed. · 07 Nov 2026
- Transcript for Earnings call for Q2 FY 2027 Financial Results held on October 27, 2026 is attached · 02 Nov 2026
- Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 is attached. · 02 Nov 2026
- Recording to earnings call held on October 27, 2026 is attached. · 27 Oct 2026
- Investor Presentation on financial results for the second quarter and half year ended as on September 30, 2026 is enclosed. · 27 Oct 2026
- Acutaas Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 27 Oct 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 is enclosed. · 27 Oct 2026
